57 related articles for article (PubMed ID: 25190507)
1. Significance of serine threonine tyrosine kinase 1 as a drug resistance factor and therapeutic predictor in acute leukemia.
Nirasawa S; Kobayashi D; Kondoh T; Kuribayashi K; Tanaka M; Yanagihara N; Watanabe N
Int J Oncol; 2014 Nov; 45(5):1867-74. PubMed ID: 25190507
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemia.
Kondoh T; Kobayashi D; Tsuji N; Kuribayashi K; Watanabe N
Exp Hematol; 2009 Jul; 37(7):824-30. PubMed ID: 19409952
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic relevance of overexpressed serine threonine tyrosine kinase/novel oncogene with kinase domain (STYK1/ NOK) mRNA in colorectal cancer.
Orang AV; Safaralizadeh R; Hosseinpour Feizi MA; Somi MH
Asian Pac J Cancer Prev; 2014; 15(16):6685-9. PubMed ID: 25169509
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells.
Zhou J; Wang F; Liu B; Yang L; Wang X; Liu Y
Oncol Res; 2017 Jul; 25(6):931-937. PubMed ID: 27983928
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
6. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.
Cui XY; Skretting G; Jing Y; Sun H; Sandset PM; Sun L
Blood Cells Mol Dis; 2013 Oct; 51(3):177-84. PubMed ID: 23725749
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
Lin M; Hu J; Liu T; Li J; Chen B; Chen X
Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
[TBL] [Abstract][Full Text] [Related]
10. Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle.
Haenisch B; Bönisch H; Cichon S; Allam JP; Novak N; Molderings GJ
Leuk Res; 2011 Sep; 35(9):1248-53. PubMed ID: 21236489
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
12. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
13. AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway.
Escobar-Díaz E; López-Martín EM; Hernández del Cerro M; Puig-Kroger A; Soto-Cerrato V; Montaner B; Giralt E; García-Marco JA; Pérez-Tomás R; Garcia-Pardo A
Leukemia; 2005 Apr; 19(4):572-9. PubMed ID: 15744353
[TBL] [Abstract][Full Text] [Related]
14. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes.
Rosales C; Juliano R
Cancer Res; 1996 May; 56(10):2302-5. PubMed ID: 8625304
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6.
Takahashi S; Harigae H; Ishii KK; Inomata M; Fujiwara T; Yokoyama H; Ishizawa K; Kameoka J; Licht JD; Sasaki T; Kaku M
Leuk Res; 2005 Aug; 29(8):893-9. PubMed ID: 15978940
[TBL] [Abstract][Full Text] [Related]
16. A novel protein tyrosine kinase NOK that shares homology with platelet- derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice.
Liu L; Yu XZ; Li TS; Song LX; Chen PL; Suo TL; Li YH; Wang SD; Chen Y; Ren YM; Zhang SP; Chang ZJ; Fu XY
Cancer Res; 2004 May; 64(10):3491-9. PubMed ID: 15150103
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
19. A correlation analysis of miRNA‑34a and its predicted target genes in leukemia.
Tang R; Li J; Yue M; Liu Z; Feng S; Tang S; Wang T
Mol Med Rep; 2014 Apr; 9(4):1283-8. PubMed ID: 24504520
[TBL] [Abstract][Full Text] [Related]
20. Expression of receptor protein tyrosine kinase tif is regulated during leukemia cell differentiation.
Dai W; Pan HQ; Ouyang B; Greenberg JM; Means RT; Li B; Cardie J
Leukemia; 1996 Jun; 10(6):978-83. PubMed ID: 8667655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]